BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12685176)

  • 21. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
    Liu SS; Tsang PC; Chan KY; Cheung AN; Chan KK; Leung RC; Ngan HY
    Tumour Biol; 2008; 29(2):105-13. PubMed ID: 18515988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical assessment of p16, COX-2 and EGFR in HPV-positive cervical squamous intraepithelial lesions.
    Balan R; Simion N; Giuşcă SE; Grigoraş A; Gheucă-Solovăstru L; Gheorghiţă V; Amălinei C; Căruntu ID
    Rom J Morphol Embryol; 2011; 52(4):1187-94. PubMed ID: 22203921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 24. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
    Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
    Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differentiation of an integrated and episomal HPV-16 DNA using real-time PCR in cervical specimens of women diagnosed with intraepithelial lesions and invasive cervical cancer].
    Szostek S; Zawilińska B; Klimek M; Wójcik K; Koprynia M; Kosz-Vnenchak M
    Ginekol Pol; 2011 Jun; 82(6):441-5. PubMed ID: 21853934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions.
    Balan R; Giuşcă S; Căruntu ID; Gheorghiţă V; Neacşu D; Amălinei C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1118-24. PubMed ID: 21495457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of HPV16 L1 capsid protein expression in cervical dysplasia with HPV16 DNA concentration, HPV16 E6*I mRNA and histologic outcome.
    Kösel S; Burggraf S; Engelhardt W; Olgemöller B
    Acta Cytol; 2009; 53(4):396-401. PubMed ID: 19697723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and viral load of 51 genital human papillomavirus types and three subtypes.
    Schmitt M; Depuydt C; Benoy I; Bogers J; Antoine J; Arbyn M; Pawlita M;
    Int J Cancer; 2013 May; 132(10):2395-403. PubMed ID: 23034864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus detection by PCR assay in a large series of high-grade squamous intraepithelial lesions with cytohistological correlation and follow-up.
    Lerma Puertas E; Otal Salaverri C; Ríos Martín JJ; Sánchez Gómez A; Jiménez Caraballo A; González-Cámpora R
    Acta Cytol; 2011; 55(5):426-32. PubMed ID: 21986169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
    Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG antibodies to HPV16, 52, 58 and 6 L1-capsids and spontaneous regression of cervical intraepithelial neoplasia.
    Matsumoto K; Yasugi T; Oki A; Fujii T; Nagata C; Sekiya S; Hoshiai H; Taketani Y; Kanda T; Kawana T; Yoshikawa H
    Cancer Lett; 2006 Jan; 231(2):309-13. PubMed ID: 16399232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer.
    Carrillo-García A; Ponce-de-León-Rosales S; Cantú-de-León D; Fragoso-Ontiveros V; Martínez-Ramírez I; Orozco-Colín A; Mohar A; Lizano M
    Gynecol Oncol; 2014 Sep; 134(3):534-9. PubMed ID: 24979052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
    Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
    Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
    Cao L; Sun PL; Yao M; Chen S; Gao H
    Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of p16INK4A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens.
    Yu L; Wang L; Zhong J; Chen S
    Cancer Cytopathol; 2010 Feb; 118(1):47-55. PubMed ID: 20069634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
    J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
    [No Abstract]   [Full Text] [Related]  

  • 37. L1 gene methylation in high-risk human papillomaviruses for the prognosis of cervical intraepithelial neoplasia.
    Oka N; Kajita M; Nishimura R; Ohbayashi C; Sudo T
    Int J Gynecol Cancer; 2013 Feb; 23(2):235-43. PubMed ID: 23314283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of antibodies against a human papillomavirus (HPV) type 16 peptide that differentiate high-risk from low-risk HPV-associated low-grade squamous intraepithelial lesions.
    Rocha-Zavaleta L; Ambrosio JP; Mora-Garcia ML; Cruz-Talonia F; Hernandez-Montes J; Weiss-Steider B; Ortiz-Navarrete V; Monroy-Garcia A
    J Gen Virol; 2004 Sep; 85(Pt 9):2643-2650. PubMed ID: 15302958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A proper triage for detecting women with high-risk human papillomavirus genotypes other than HPV16/18.
    Wang JJ; Lyu LP; Hu QW; Wan ZQ; Dong J; Pan M; Shen WW; Zhang S
    Eur J Obstet Gynecol Reprod Biol; 2017 Dec; 219():113-118. PubMed ID: 29101837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus L1 capsid protein and human papillomavirus type 16 as prognostic markers in cervical intraepithelial neoplasia 1.
    Choi YS; Kang WD; Kim SM; Choi YD; Nam JH; Park CS; Choi HS
    Int J Gynecol Cancer; 2010 Feb; 20(2):288-93. PubMed ID: 20134272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.